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Background: Traditional folk medicinal plants have recently become popular and are widely used for primary
health care. Since Thailand has a great diversity of indigenous (medicinal) plant species, this research investigated
52 traditionally used species of Thai medicinal plants for their in vitro cytotoxic, antioxidant, lipase inhibitory and
antimicrobial activities.
Methods: The 55 dried samples, derived from the medicinally used parts of the 52 plant species were sequentially
extracted by hexane, dichloromethane, ethanol and water. These 220 extracts were then screened for in vitro
(i) cytotoxicity against four cell lines, derived from human lung (A549), breast (MDA-MB-231), cervical (KB3-1)
and colon (SW480) cancers, using the MTT cytotoxicity assay; (ii) antioxidant activity, analyzed by measuring
the scavenging activity of DPPH radicals; (iii) lipase inhibitory activity, determined from the hydrolytic reaction
of p-nitrophenyllaurate with pancreatic lipase; and (iv) antimicrobial activity against three Gram-positive and two
Gram-negative bacteria species plus one strain of yeast using the disc-diffusion method and determination of
the minimum inhibitory concentration by the broth micro-dilution assay.
Results: The crude dichloromethane and/or ethanol extracts from four plant species showed an effective in vitro
cytotoxic activity against the human cancer cell lines that was broadly similar to that of the specific chemotherapy
drugs (etoposide, doxorubicin, vinblastine and oxaliplatin). In particular, this is the first report of the strong in vitro
cytotoxic activity of Bauhinia strychnifolia vines. The tested tissue parts of only six plant species (Allium sativum,
Cocoloba uvifera, Dolichandrone spathacea, Lumnitzera littorea, Sonneratia alba and Sonneratia caseolaris) showed
promising potential antioxidant activity, whereas lipase inhibitory activity was only found in the ethanol extract
from Coscinum fenestratum and this was weak at 17-fold lower than Orlistat, a known lipase inhibitor. The highest
antimicrobial activity was observed in the extracts from S. alba and S. caseolaris against Pseudomonas aeruginosa
and Candida albicans, respectively.
Conclusion: The Thai medicinal plant B. strychnifolia is first reported to exert strong in vitro cytotoxic activities
against human cancer cell lines and warrants further enrichment and characterization. The broad spectrum of
the biological activities from the studied plant extracts can be applied as the guideline for the selection of
Thai medicinal plant species for further pharmacological and phytochemical investigations.
Keywords: Antimicrobial, Antioxidant, Cytotoxic, Lipase inhibitory, Thai medicinal plants* Correspondence: wanchai.a@chula.ac.th
5Department of Microbiology, Faculty of Science, Chulalongkorn University,
Phayathai Road, Bangkok 10330, Thailand
Full list of author information is available at the end of the article
© 2012 Kaewpiboon et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Kaewpiboon et al. BMC Complementary and Alternative Medicine 2012, 12:217 Page 2 of 8
http://www.biomedcentral.com/1472-6882/12/217Background
Recent investigations into plants that have been the basis
of traditional medicine for a long time have revealed a
significant number of novel metabolites with potent
pharmacological properties [1-3]. For example, the che-
motherapeutic drug, pacitaxel (Taxol) was initially dis-
covered from the bark of the Himalayan Yew tree by
screening for anticancer activity in plant extracts [4].
Various types of plants have been used not only for diet-
ary supplements but also as traditional folk treatments
for many health problems [5]. Indeed, the long history
of folk medicine demonstrates the potential of plants as
sources of bioactive compounds [6]. Traditional medi-
cine is widely used throughout Thailand [7], with both
ready-made preparations and herbal drugs being used,
and a number of these Thai medicinal plants have pro-
vided the foundation for modern pharmaceuticals and
drug leads [8]. Thailand has a great diversity of indigen-
ous (medicinal) plant species and hence is a potential
source for bioactive compounds, including those with
potential antitumor [7,9], antioxidant [10,11], anti-lipase
(and so potential antiobesity) [9,12] and antimicrobial
activities [13,14].
Since current pharmacological reagents are restricted
by the increasing spread and evolution of resistance
and/or their undesired side effects, and are often difficult
to synthesize as the pure bioactive stereoisomer, investi-
gations to explore novel drugs, or those that can act as
templates for the development of new therapeutic agents
appears imperative. Therefore, the aim of this study
was to screen for potential in vitro cytotoxic, antioxi-
dant, lipase inhibitory and antimicrobial activities from
the crude extracts of the folk medicinally used parts of
52 species of Thai medicinal plants.
Methods
Chemicals and reagents
Ascorbic acid, chloramphenicol, dimethyl sulfoxide
(DMSO), doxorubicin, etoposide, p-iodonitrotetrazolium
violet, p-nitrophenyllaurate (p-NPL) vinblastine, oxali-
platin, porcine pancreatic lipase (PPL; Type II: from por-
cine pancreas), 2,2-diphenyl-1-picryhydrazyl (DPPH)
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromine (MTT) were purchased from Sigma (USA).
Amphotericin B was purchased from Bristol-Myers
Squibb (France). Orlistat (XenicalW) was purchased from
Roche (Italy). Cell culture media and antibiotics were
purchased from Gibco (USA). Fetal bovine serum (FBS)
was purchased from Hyclone (USA). All other chemicals
were of analytical grade.
Plant materials
Fifty two types of Thai medicinal plants were selected
based on traditional medicinal uses. These plants weregrown in Pom Phra Chulachomklao Mangrove Forests,
Phra Chulachomklao Fort, Samut Prakarn (Additional
file 1: Table S1). The taxonomic identification was done
by the members of the Mangrove Forest Restoration
and Regeneration Project during 2004 to 2008 from
the Metropolitan Electricity Authority, using the avail-
able taxonomic key with the aid of the relevant literature
(e.g. the ecology of mangrove plants [15] and flora of
Thailand). The specimens, collected during August to
October 2010, were dried, ground into a fine powder
and then extracted as previously described in Mothana
et al. [16] with minor modification. Twenty grams of the
sample powder was sequentially extracted with hexane,
dichloromethane (DCM) and ethanol (300 mL each),
respectively, by Soxhlet extraction for 8 h. The residues
were dried overnight and then extracted with 300 mL
water in a shaking water-bath at 60°C for 8 h. The
obtained crude hexane, DCM and ethanol extracts
were evaporated to dryness on a rotary evaporator while
the crude water extract was freeze dried. The dried
samples were then stored at −20°C until use.
In vitro cytotoxic activity assay
The in vitro cytotoxic activity of the crude extracts was
determined from the mitochondrial activity of cell lines
which represent the number of viable cells after the
treatment, by using the MTT cytotoxic assay as previ-
ously described [17] on four different human cell lines in
tissue culture. The non-small cell lung adenocarcinoma
(A549) and breast cancer (MDA-MB-231) cell lines were
purchased from the American Type Culture Collection
(Manassas, VA, USA). The cervical (KB3-1) and colon
(SW480) cancer cell lines were kindly provided by
Professor Gottesman (Laboratory of Cell Biology, Na-
tional Cancer Institute, National Institute of Health,
MD, USA) and Dr. Chanida Vinayanuwattikun (Faculty
of Medicine, Chulalongkorn University), respectively.
Cell suspensions in complete medium (CM) (either
RPMI (A549 and SW480) or DMEM (MDA-MB-231
and KB3-1), supplemented in both cases with 10% (v/v)
FBS, 100 units/mL penicillin and 100 μg/mL strepto-
mycin), were seeded into each well of a 96-well plate
(5 x 103 cells per well) and incubated at 37°C with 5%
(v/v) CO2. After 24 h, the crude extracts at five different
concentrations in DMSO (two-fold serial dilutions from
100 to 6.25 μg/mL) dissolved in the respective CM were
then added into the wells and further incubated for 72 h.
Thereafter, the media in the wells were removed and
replaced with fresh CM containing 5 mg/mL MTT and
incubated at 37°C for 2 h to allow the formation of the
insoluble formazan crystal by the mitochondrial active
(viable) cells. The media were then removed, 100 μL
DMSO was added to lyse the cell membranes and
solubilize the formazan crystals and the absorbance was
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Microplate Reader (Holliston, MA, USA). The percent-
age of cell survival was calculated from Eq. (Eq. 1).
% Cell survival ¼ ODT=ODCð Þ  100 ðEq:1Þ
where ODT and ODC are the mean absorbance of the
treated and the control cells, respectively.
The concentration of the extract which caused a half
maximal inhibition of cell proliferation (IC50), as deter-
mined by the MTT assay, was obtained from a semilog
plot of the crude extract concentrations against the per-
centage of cell survival. Etoposide (200–0.39 μg/mL),
doxorubicin (50–0.1 μg/mL), vinblastine (100–0.2 μg/mL)
and oxaliplatin (100–0.2 μg/mL) were used as the specific
positive controls for the A549, MDA-MB-231, KB3-1 and
SW480 cell lines, respectively.
DPPH radical scavenging (antioxidant activity) assay
The DPPH free radical scavenging assay was used for
the evaluation of the antioxidant activity of the crude
extracts, as previously described [16]. The dried crude
hexane, DCM, ethanol and water extracts were each dis-
solved to five different concentrations in ethanol (10, 50,
100, 500 and 1000 μg/mL). The reaction mixture, con-
taining 100 μL of the desired extract concentration in
ethanol, 25 μL of 1 mM DPPH and 75 μL of ethanol
were added into a 96-well plate and incubated at 37°C
for 30 min. The absorbance at 517 nm was then moni-
tored from the yellowish solution in a Biochrom Asys
UVM 340 Microplate Reader. The DPPH radical scaven-
ging activity was then calculated from Eq. (Eq. 2).
% of DPPH radical scavenging activity
¼ A0  A1  A2ð Þ=A0ð Þ½   100 ðEq:2Þ
where A0, A1 and A2 are the absorbance of the DPPH
(no crude extract), the crude extract with DPPH and the
crude extract without DPPH, respectively.
The concentration which caused a half-maximal
reduced DPPH radical level (EC50) was then determined.
Extracts with an EC50 < 10 μg/mL were considered as
having a high level of antioxidant activity [18]. Ascorbic
acid (10, 50, 100, 500 and 1000 μg/mL) was used as a
positive control.
Determination of the lipase inhibitory activity
The lipase inhibitory activity of the crude extracts was
estimated from the ability to inhibit the in vitro porcine
pancreatic lipase activity as previously described [19]
with slight modification. Briefly, the dry crude ethanol
and water extracts were dissolved in 50 mM Tris–HCl
pH 8.5 containing 50% (v/v) DMSO to a concentration
of 50 mg/mL. The assay mixture contained 10 μL of one
of five different concentrations (two-fold serial dilutionsfrom 2.5 to 0.156 mg/mL) of the crude extracts, 12 μL
of 20 mg/mL of PPL (type II) in 50 mM Tris–HCl pH
8.5 and 10 μL of 5.1 mM p-NPL in ethanol. The lipase
activity was determined from the hydrolysis of p-NPL by
measuring the absorbance at 410 nm of the p-nitrophe-
nol product formed at 37°C for 5 min using a FLUOstar
OPTIMA micro reader (BMG LABTECH, Offenburg,
Germany). The lipase inhibitory activity was expressed
as the percentage of the decrease in A410 when PPL
was incubated with the crude extracts compared to the
negative control (solvent only), and was calculated from
Eq. (Eq. 3).
% of enzyme inhibition ¼ E T=E½   100 ðEq:3Þ
where E and T are the absorbance of the reaction with-
out and with the crude extract, respectively.
The concentration of the extract which caused a half
maximal inhibition of the lipase activity (IC50) was
obtained from a semilog plot of the crude extract concen-
trations against the percentage of enzyme inhibition. Orli-
stat (250–0.49 μg/mL) was used as the positive control.
Antimicrobial assay
Three Gram-positive (Bacillus subtilis (MCCU0351),
Micrococcus luteus (MCCU0350) and Staphylococcus
aureus (MCCU0352)) and two Gram-negative (Escheri-
chia coli (MCCU0349) and Pseudomonas aeruginosa
(MCCU0359)) bacterial strains, plus the yeast (Candida
albicans) were used for the antimicrobial screening.
The antimicrobial activities of the crude ethanol and
water extracts were determined using the disc-diffusion
and broth micro-dilution assays [16]. For the disc-
diffusion assay, the various microbes were spread at
1.5 x 107 cells/plate on 9-cm diameter nutrient agar petri
dishes. Sterile filter paper discs of 6 mm in diameter
(Whatman, cat. NO. 1442125, lot 577125) were impreg-
nated with 2 mg of the crude extract dissolved in 5% (v/v)
ethanol, dried and then placed on the surface of the
spread agar plates. They were kept for 2 h in a 4°C
refrigerator to enable pre-diffusion of the crude extracts
and then further incubated at 37°C for 18 h, except for
M. luteus (room temperature for 48 h) and C. albicans
(30°C for 48 h) [20]. At the end of the incubation,
the antimicrobial activity was evaluated by measuring
the diameter of the inhibition zone. An inhibition zone
of 10 mm in diameter or more was regarded as repre-
senting a high antimicrobial activity. Chloramphenicol
(20 μg/disc) and amphotericin B (40 μg/disc) were used as
positive controls for the bacteria and yeast, respectively.
The crude extracts that revealed a positive antimicro-
bial activity in the disc-diffusion assay were then evalu-
ated by the broth micro-dilution assay to determine
the minimal inhibitory concentration (MIC) against the
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minor modifications. Within sterile 96-well plates, two-
fold serial dilutions of the selected crude extracts were
prepared (in duplicate) in the appropriate broth contain-
ing 5% (v/v) DMSO to produce a concentration range
of 1,000 to 7.8 μg/mL. The bacterial cell suspension, at
0.5 McFarland standards (approximately 1.5 × 108 colony
forming units/mL) [21] was added into each well, except
for the blank wells which served as extract and media
sterility controls. Control cultures for bacterial growth
without the crude extract were also included in each
plate. The plates were then incubated at 37°C for 18 h,
where after 20 μL of a 0.04% (w/v) p-iodonitrotetrazo-
lium violet solution was then added to each well and
incubated for 30 min. A change in color from yellow
to pink, indicating the reduction of the dye from the
bacterial growth, was observed. The MIC of the crude
extract was determined from the lowest concentration
at which no growth of microorganism, as determined
by the color change, was observed. Similarly, two-fold
dilutions of chloramphenicol (250–7.81 μg/mL) or ampho-
tericin B (500–15.63 μg/mL) were used as a positive con-
trol for the bacteria and yeast, respectively.
Results
Additional file 1: Table S1 lists the ethnobotanical data
of the investigated plant species illustrating their botan-
ical names, the part(s) of the plant used for extraction,
the traditional folk medicinal uses of these plant tissues,
and the yield obtained from each extract (as % by dry
weight of the total dry weight). A total of 220 extracts,
representing 52 plant species (since two tissue parts
were used for each of Bauhinia strychnifolia, Moringa
oleifera and Solanum trilobatum), were screened for
in vitro cytotoxic, antioxidant, lipase inhibitory and anti-
microbial activities.
In vitro cytotoxic activity
Of the 52 plant species assayed, the extracts from
only four species (B. strychnifolia vines, Coscinium
fenestratum stems, Eurycoma longifolia roots and
Kalanchoe pinnata leaves) displayed potential in vitro
cytotoxicity against the four human cancer cell lines
tested (Additional file 1: Table S2).
In terms of the deduced IC50 values, the crude water
extracts had only a weak (> 20 μg/mL) to essentially no
activity in all cases, but for the other less polar extracts
they varied between the cell lines, plant species and sol-
vents used in the extraction. Nevertheless, typically the
crude DCM and ethanol extracts were more active sug-
gesting the bioactive components have a moderate to
low polarity.
Overall, the vine extracts from B. strychnifolia were
the most effective against three of the four humancancer cell lines. However, it was still effective against
the fourth (SW480) cell line. The highest cytotoxic activ-
ity (IC50 of 0.28 μg/mL) was obtained against the MDA-
MB-231 cell line by the crude hexane extract of
B. strychnifolia vines, with the crude DCM extract being
strongly cytotoxic against the A549 and KB3-1 cell lines
(IC50 value of 1.16 and 1.86 μg/mL, respectively). In fact,
this is the first report of the in vitro cytotoxic activity
of this interesting plant against human transformed
cell lines.
For the remaining three plant species with positive
in vitro cytotoxicity, the crude DCM and ethanol
extracts of K. pinnata leaves showed a better overall
in vitro cytotoxicity than the other two plant species, al-
though these K. pinnata leaf extracts were not that ef-
fective against the A549 cell line. The crude DCM and
ethanol extracts from C. fenestratum stems were effect-
ive against the KB3-1 cell line (IC50 values of 3.25 and
2.18 μg/mL, respectively). Although the extracts from
E. longifolia roots were in general the least effective of
the four positive plant species, its DCM and ethanol
extracts were strongly cytotoxic against the MDA-MB-231
cell line (IC50 values of 1.6 and 1.2 μg/mL, respectively).
Antioxidant and lipase inhibitory activities
With respect to the antioxidant activity, an EC50 value of
less than 10 μg/mL in the DPPH radical scavenging
assay is generally considered to be effective in this work.
However, the positive control of ascorbic acid under
these assay conditions was outside this limit (EC50 = 12
± 1.29 μg/mL). Of the 220 plant extracts, only some of
the crude water and ethanol extracts, but not the hexane
and DCM extracts, from six plant species (see below)
revealed potential DPPH radical scavenging activity.
Therefore, it can be speculated that the principal bio-
active components are relatively polar compounds and
different to those with cytotoxic activities.
Of the 110 crude ethanol and water extracts evaluated
from the 52 plant species, extracts from only six plant
species were found to have an effective DPPH radical
scavenging activity, ranging in the order (lowest to high-
est EC50 value) of Sonneratia caseolaris leaves, Cocco-
loba uvifera leaves, Sonneratia alba leaves, Lumnitzera
littorea leaves, Allium sativum bulbs and Dolichandrone
spathacea leaves (EC50 values of 1.92 ± 0.38, 3.08 ± 1.01,
3.27 ± 0.53, 4.00 ± 0.25, 4.23 ± 0.67 and 5.17 ± 0.29 μg/mL,
respectively).
With respect to the crude water extracts, three
(S. alba, S. caseolaris and L. littorea) of the six plant
species with effective ethanol extracts also had effec-
tive DPPH radical scavenging activity (EC50 values of
6.43 ± 2.29, 7.25 ± 1.52 and 7.27 ± 0.64 μg/mL, respect-
ively), but no other extracts were effective. Although the
water extracts were less effective than the corresponding
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derived from sequential (ethanol before water), poten-
tially non-exhaustive extractions that will vary in their
compositions and so it cannot be inferred that they
represent different component(s) or specific activities.
With respect to the lipase inhibition, the crude ethanol
extract from C. fenestratum was the only one found to
display effective activity. Nevertheless, this was weak
(IC50 value of 160 ± 0.02 μg/mL), compared to that for
the positive control of Orlistat (IC50 value of 9.25 ±
1.25 μg/mL).
Antimicrobial activity
Using the disc-diffusion assay and taking an inhibition
zone of ≥10 mm diameter as the indication of a strong
antimicrobial activity [22], from the 110 crude ethanol
and water extracts screened from 52 plant species, those
from only four plant species were found to exhibit a
strong antimicrobial activity (Additional file 1: Table S3).
The ethanol extracts of C. fenestratum stems showed the
broadest range of activity, inhibiting all of the three
tested Gram-positive bacteria (S. aureus, B. subtilis and
M. luteus), and one (E. coli) of the two Gram-negative
bacteria as well as the yeast strain (C. albicans). How-
ever, the crude ethanol extract from Anacardium occi-
dentale leaves and S. caseolaris leaves were also effective
against E. coli.
For the aqueous extracts, that from S. alba leaves was
found to inhibit one (M. luteus) of the three tested
Gram-positive bacteria, both tested Gram-negative bac-
teria (E. coli and P. aeruginosa) and the yeast strain
(C. albicans), whilst that from S. caseolaris leaves could
inhibit E. coli and C. albicans. The extracts from A. occi-
dentale leaves, therefore, appeared to potentially be
specific for Gram-negative bacteria.
To obtain the MIC of the crude extracts, the broth
micro-dilution assay was utilized to screen those crude
water and ethanol extracts that were positive by the
disc-diffusion assay. The results (Additional file 1:
Table S3) showed that the crude ethanol extract of
C. fenestratum stems inhibited the three tested Gram-
positive and one (E. coli) of the two tested Gram-negative
bacteria strains plus C. albicans equally and effectively
(MIC values of 500 μg/mL), whilst the only other extract
to be active against Gram-positive bacteria (water extract
of S. alba on M. luteus) also had a MIC value of 500 μg/
mL. However, a lower MIC was obtained against the
Gram-negative bacteria P. aeruginosa and the yeast C.
albicans from the aqueous extracts of S. alba and S. case-
olaris (125 μg/mL). These MIC values are typically higher
than those for the positive control of chloramphenicol for
bacteria (MIC of ~8 to 32 μg/mL, except for P. aerugi-
nosa at 125 μg/mL) but broadly comparable to that for
amphotericin B for the yeast (MIC of 250 μg/mL).However, these crude extracts are likely to contain many
non-bioactive compounds (in mass) and so the actual spe-
cific activities after enrichment would potentially be higher.
Discussion
In vitro cytotoxic activity
According to the United States National Cancer Institute
plant screening program, a plant extract is generally
considered to have an active cytotoxicity effect if the
IC50 value following incubation between 48 to 72 h, is
20 μg/mL or less [23].
The relevant tissue(s) (in terms of the tissue(s) used in
folk medicine) from 52 species of medicinal plants in
Thailand were screened as their crude hexane, DCM,
ethanol and water extracts for in vitro cytotoxic activity
against four human transformed (cancer) cell lines. The
highest cytotoxic activity was obtained from the crude
hexane extract obtained from the vines (but not leaves)
of B. strychnifolia against the MDA-MB-231 cell line.
Moreover, this extract also had potential strong acti-
vity against the KB3-1 cell line, whilst the crude DCM
extract exhibited cytotoxic activity against the A549 and
KB3-1 cell lines. From the results, the derived IC50
values for the crude hexane and DCM extracts from the
vines of B. strychnifolia are not that different on each
cell line from the respective positive controls (etoposide,
doxorubicin, vinblastine and oxaliplatin). Assuming no
strong synergy among all components in the extract, it
can be implied that the bioactive component(s) in these
fractions could be far more potent than the standard
reference drugs and so merits their enrichment and fur-
ther characterization.
Clinically, B. strychnifolia has been applied for the
treatment of human food poisoning diarrhea [24] and
also in 2011 as an anti-HIV-1 agent [25]. Nevertheless,
the antitumor activity has never been reported. As a
consequence, this work appears to be the first report on
the antitumor activity of B. strychnifolia.
The crude DCM extract of C. fenestratum showed
in vitro cytotoxicity against the KB3-1 cell line, which is
consistent with the reported antiproliferative activity
against the human colorectal carcinoma (HCT-116) cell
line [26], where it apparently induces expression of
the peroxisome proliferator-activated receptor γ and
pro-apoptotic genes.
The crude DCM and ethanol extracts of E. longifolia
roots exhibited cytotoxic activity against the MDA-MB-
231 cancer cell line, which has been reported previously
on the human breast cancer cell line MCF-7 where the
inhibition was linked to the induction of apoptotic cell
death [27,28]. In addition, from nearly 65 compounds
isolated from the roots of E. longifolia, eight were found
to demonstrate strong cytotoxicity towards the human
lung cancer (A549) cell line and some of these were also
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it appears that the crude alcohol extracts from E. long-
ifolia roots may exhibit a preferential or specific cyto-
toxicity against breast cancer.
The bufadienolide isolated from the methanol extract
of K. pinnata has been reported to be a potential cancer
chemotherapeutic agent since it inhibits the tumor
promoting activity of Epstein-Barr Virus [30]. Here, we
found that the crude ethanol extract from the leaves of
this plant inhibited the growth of the KB3-1 cell line,
which was developed from human papilloma virus
infected cells. Hence, it is possible that the ethanol
extracts affect the regulation of some viral proteins that
control cell division.
Overall, the crude hexane and DCM extracts were
more active than the corresponding aqueous and ethanol
ones, suggesting that the active compound(s) against the
cell lines in these plants are of low polarity. In addition,
as mentioned before, since these are crude extracts and
may contain many non-active components then the IC50
values reported here may in fact be far higher than those
of the actual bioactive component(s) in the extracts,
assuming no strong synergy between different compo-
nents. Therefore, these results support that the bioactivity-
guided enrichment of these fractions is merited.
Antioxidant and lipase inhibitory activity
With respect to the antioxidant activity, the crude etha-
nol and water extracts from only six of the 52 investi-
gated plants showed any effective free radical scavenging
activity in the DPPH assay when compared to that of
the ascorbic acid reference standard. The hexane and
DCM extracts did not exert any detectable antioxidant
activity in this study. This result is similar to the study
on Fenugreek seeds (Trigonella foenum-graecum) which
showed that the highest antioxidant activity was found
in the ethanol and methanol extracts followed by the
aqueous extract with only low activities in the hexane
and DCM extracts [31]. Moreover, most of the 52 plants
investigated in this study naturally occur (and were
obtained from) within mangrove forest areas, which are
typically rich sources of phenolic compounds, such as
flavonoids [32], to protect the plants from UV radiation
[33,34]. As a matter of fact, a linear relationship between
the flavonoid content and the antioxidant activity has
already been reported [35].
With respect to the lipase inhibitory activity, only the
crude ethanol and water extracts were evaluated. The
low polarity compounds including the natural lipids in
the tissue(s) could be extracted by hexane and DCM at
sufficiently high concentrations as to interfere in the
assay by acting as alternative but unquantified substrates
for the lipase providing false positives and potentially
masking genuine weak and moderate positives. However,all but one of the 110 water and ethanol extracts were
found to be inactive. The exception was the ethanol
extract from C. fenestratum stems that exhibited a weak
lipase inhibitory activity (IC50 value of 160 μg/mL)
that had a 17.3-fold lower IC50 value than that for
Orlistat, a known lipase inhibitor. Nevertheless, it is a
crude extract, and so the actual IC50 of the active com-
ponent(s) may be significantly higher. The lipase inhibi-
tory activity from this plant (the first report) gives a
suggestion of the potential to screen for novel plant
compounds with anti-lipase activity. These may be of
clinical dietary use in countering the problems of human
obesity. Thus, it may be interesting for further studies
to fractionate the crude hexane and DCM extracts to
remove the natural lipid content and screen the other
fractions for anti-lipase activity.
Antimicrobial activity
Unfortunately, the crude hexane and DCM extracts,
although soluble in DMSO were not soluble in the 5% (v/v)
DMSO-nutrient broth media used for the broth micro-
dilution assay, where higher DMSO levels are themselves
inhibitory in the assay. Therefore, only the 110 crude etha-
nol and water extracts were screened for antimicrobial
activity. Significant antimicrobial activities (inhibition
zones ≥ 10 mm) were obtained from the extracts of only
four plant species, with MIC values of ≤ 500 μg/mL (as
determined by subsequent broth assays).
Of the four plants with antimicrobial activity, the
crude ethanol extract of C. fenestratum stems displayed
a broad range of antimicrobial effects against all tested
microorganisms except P. aeruginosa. Moreover, it
has been previously reported to inhibit the growth of
Propionibacterium acnes and Staphylococcus epidermidis
[36], whereas the methanol extract of this plant was
reported to inhibit the growth of S. aureus, B. subtilis
and E. coli [37].
The aqueous extract from the leaves of S. alba displayed
an antimicrobial activity against both tested Gram-negative
bacteria (E. coli and P. aeruginosa), one (M. luteus) of the
three tested Gram-positive bacteria (M. luteus), and the
yeast C. albicans. In agreement with this is that both
the methanol and ethyl acetate extracts have been reported
to have antimicrobial activity against Gram-positive (Bacil-
lus cereus and S. aureus) and Gram-negative (E. coli) bac-
teria [38], but the inhibition activity against P. aeruginosa
and C. albicans is newly reported here.
Although the results of this work are consistent with
those reported by Tao et al. [39] in that the ethanol
extract of S. caseolaris had no antimicrobial activity
against B. subtilis, S. aureus, P. aeruginosa and E. coli,
our ethanol extract did inhibit the growth of E. coli.
In addition, we found that the crude water extract
of S. caseolaris leaves could inhibit the growth of
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http://www.biomedcentral.com/1472-6882/12/217C. albicans, which is consistent with the report that not
only the ethanol leaf extract but also the methanol ex-
tract of the cork of this plant could inhibit C. albicans
[40]. Thus, these two species from the family Sonneratia-
ceae merit further investigation for antimicrobial agents.
Finally, the ethanol extract from the leaves of A. occi-
dentale demonstrated antimicrobial activity against E. coli
and P. aeruginosa, which is similar to that previously
reported [41-43], but is in contrast with the previous
report that the ethanol extract of this plant’s leaves also
inhibited M. luteus, S. aureus and B. subtilis [41,42],
which was not observed in the present study.
Overall, the ethanol and aqueous extracts exhibited
potential antimicrobial activity and merit further bio-
activity guided fractionation to obtain the bioactive com-
ponent(s). However, since the crude hexane and DCM
extracts could not be screened, their initial fractionation
and assay for antimicrobial activity may be of value, with
further bioactivity guided fractionation as required.
Conclusion
The in vitro cytotoxic, antioxidant, lipase inhibitory and
antimicrobial activities of 52 species of Thai medicinal
plants were studied using the tissue source(s) that are
used in traditional folk medicine. The crude hexane ex-
tract from the vines of B. strychnifolia was found to
exert a strong in vitro cytotoxic activity against human
cancer cell lines and certainly merits further enrichment
to isolate the potentially promising bioactive component
(s). This work provides the basic data base of selected
Thai medicinal plants species that can be used to iden-
tify potential novel bioactive compounds for pharmaco-
logical and phytochemical investigations. However, the
other parts of each plant may not be used in folk medi-
cine for reasons other than a lack of bioactive com-
pound(s), such as digestibility, taste or presence of other
deleterious components, and so the other tissues of posi-
tive plants should be screened. Regardless, the simple
approach of using the knowledge of folk medicine as a
first guide to select plants for pharmacological screening
appears validated, although it should be extended to
include not only the other tissue parts of positive plants,
but also close phylogenetic relatives and cultivars.
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